FBN’s Charles Payne, Divine Capital CEO Dani Hughes, A&G Capital CIO Hilary Kramer, FBN contributor Anthony Scaramucci, Tea Party News Network News Director Scottie Nell Hughes and Penn Financial Group founder Matt McCall on the opportunities for investors in health care.
Eagle Bay Capital founder J.C. Parets and Zor Capital Managing Director Joe Fahmy on the outlook for the markets.
FBN’s Charles Payne, Douglas C. Lane & Associates’ Matthew Veto, Fairfax Global Markets CEO Paul Dietrich, A&G Capital CIO Hilary Kramer, retail analyst Hitha Herzog and Penn Financial Group founder Matt McCall on investing in ‘sin’ stocks.
NRF Vice President Jonathan Gold discusses the economic impact of a full port shutdown.
Former Pennsylvania Congressman Jim Greenwood discusses what he sees moving the needle on DNA patentability.
Recombine CEO Alexander Bisignano discusses how his company is trying to improve genetic testing.
Ariel Investments Vice Chairman Charles Bobrinskoy discusses the deal between Pfizer and Hospira and how he’s allocating capital.
Canaccord Genuity U.S. Portfolio Strategist Tony Dwyer and Glenmede Director of Investment Strategy Jason Pride discuss money flow into the health-care sector.
FBN’s Liz MacDonald on Pfizer’s multi-billion dollar bet on Hospira.
JPM Private Bank Global Equity Strategy Head Steven Rees, Argus Research President John Eade and Skybridge Founder Anthony Scaramucci discuss earnings growth and how to allocate capital.
FBN’s Charles Payne, BNP Paribas Cash Equity Trading Head Darren Wolfberg A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling and Penn Financial Group founder Matt McCall on the outlook for OPKO Health.
M.D. Sass CEO Martin Sass and Lido Isle Advisors CEO Jason Rotman break down money buys for portfolio.
Priceline Founder Jay Walker on launching a managing patent service.
U.S. Bank Wealth Management Senior Portfolio Manager Eric Wiegand and Veracruz LLC Founder Steve Cortes discuss their outlook for the Fed, rate hikes and the markets.
FBN’s Cheryl Casone, Portfolio Wealth Advisors Co-Founder Lee Munson and Kaltbaum Capital Management President Gary Kaltbaum on where to invest as the Russell 2000, putting money in small caps and the homebuilders industry.
Dr. Kevin Campbell of the UNC Department of Medicine discusses two new studies that may be game changers for people with peanut allergies.
RJ O’Brien Managing Director John Brady and S&P Capital IQ Managing Director Mike Thompson discuss the corporate tax debate and where they would put money in today’s market.
FBN’s Deirdre Bolton, A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling, Tea Party News Network News Director Scottie Nell Hughes and Penn Financial Group founder Matt McCall on Greece’s impact on the U.S. markets.
Barron’s Editor and President Ed Finn discusses the magazine’s cover story of America’s top 1,200 financial advisors, the Nasdaq’s run at 5K and Apple stock.
OppenheimerFunds Chief Economist Jerry Webman and GFI Group’s John Spallanzani discuss the ECB minutes, the Greek debt crisis and the tech and airline sectors.